CD19-targeted HSP90 inhibitor nanoparticle combined with TKIs reduces tumor burden and enhances T-cell immunity in murine B-cell malignancies
发布时间:2026-03-11
点击次数:
- 发布时间:
- 2026-03-11
- DOI码:
- 10.7150/thno.106758
- 论文名称:
- CD19-targeted HSP90 inhibitor nanoparticle combined with TKIs reduces tumor burden and enhances T-cell immunity in murine B-cell malignancies
- 发表刊物:
- Theranostics
- 第一作者:
- 马运峰
- ISSN号:
- 1838-7640
- 是否译文:
- 否
- 收录刊物:
- SCI




